The commercialization of genome-editing technologies
暂无分享,去创建一个
Ali Khademhosseini | Sun Choi | Katelyn Brinegar | Ali K Yetisen | Emily Vallillo | Guillermo U Ruiz-Esparza | Anand M Prabhakar | Seok-Hyun Yun | A. Khademhosseini | S. Yun | Anand M. Prabhakar | G. U. Ruiz‐Esparza | Katelyn N. Brinegar | Ali K Yetisen | Sun Choi | E. Vallillo
[1] Darryl Macer,et al. Universal Declaration On The Human Genome and Human Rights , 1997, Nursing ethics.
[2] Who owns CRISPR-Cas9 in Europe? , 2014, Nature Biotechnology.
[3] S. Rosenberg,et al. Cancer Regression in Patients After Transfer of Genetically Engineered Lymphocytes , 2006, Science.
[4] J. Doudna,et al. The new frontier of genome engineering with CRISPR-Cas9 , 2014, Science.
[5] Jacob S. Sherkow. Who Owns Gene Editing? Patents in the Time of CRISPR , 2016 .
[6] Jeffrey D Wolt,et al. The Regulatory Status of Genome‐edited Crops , 2015, Plant biotechnology journal.
[7] Jacob S. Sherkow. Patents in the time of CRISPR: Who owns gene editing? , 2016 .
[8] Neville E. Sanjana,et al. Genome-Scale CRISPR-Cas9 Knockout Screening in Human Cells , 2014, Science.
[9] Jacob S. Sherkow. CRISPR: Pursuit of profit poisons collaboration , 2016, Nature.
[10] Gang Bao,et al. CRISPR/Cas9 systems have off-target activity with insertions or deletions between target DNA and guide RNA sequences , 2014, Nucleic acids research.
[11] Ying Sun,et al. CRISPR/Cas9-mediated gene editing in human tripronuclear zygotes , 2015, Protein & Cell.
[12] L. Yueh,et al. Patent laws and innovation in China , 2009 .
[13] Emily Waltz,et al. Gene-edited CRISPR mushroom escapes US regulation , 2016, Nature.
[14] Jin-Soo Kim,et al. Analysis of off-target effects of CRISPR/Cas-derived RNA-guided endonucleases and nickases , 2014, Genome research.
[15] William Bains,et al. Wasting cash—the decline of the British biotech sector , 2009, Nature Biotechnology.
[16] Yaojin Peng. The morality and ethics governing CRISPR–Cas9 patents in China , 2016, Nature Biotechnology.
[17] N. Patron,et al. Induction of targeted, heritable mutations in barley and Brassica oleracea using RNA-guided Cas9 nuclease , 2015, Genome Biology.
[18] D. Go,et al. The Impact of CRISPR/Cas9-Based Genomic Engineering on Biomedical Research and Medicine. , 2016, Current molecular medicine.
[19] Kiran Musunuru,et al. Expanding the genetic editing tool kit: ZFNs, TALENs, and CRISPR-Cas9. , 2014, The Journal of clinical investigation.
[20] B. Wiedenheft,et al. The history and market impact of CRISPR RNA-guided nucleases. , 2015, Current opinion in virology.
[21] V. Iyer,et al. Efficient genome modification by CRISPR-Cas9 nickase with minimal off-target effects , 2014, Nature Methods.
[22] Sara Reardon,et al. Chinese scientists genetically modify human embryos , 2015, Nature.